MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital
MariMed restructures Series B shareholder obligation and extends the maturity… NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) — MariMed Inc. (MariMed or the Company) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company

